Urolog. pro Praxi, 2009; 10(3): 166-167

Management of urinary incontinence with clean intermittent autocatheterization and fesoterodine in patiens with sclerosis multiplex

MUDr. Květoslav Novák
Urologická klinika 1. LF UK a VFN Praha

The case is presented as a treatment example of urinary incontinence in neurogenic bladder in patients with multiple sclerosis. The

significant treatment effect was reached by combination of clean intermittent autocatheterization and administration of fesoterodine

at intolerance of others antimuscarinics.

Keywords: incontinence, sclerosis multiplex, spasmolytics.

Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novák K. Management of urinary incontinence with clean intermittent autocatheterization and fesoterodine in patiens with sclerosis multiplex. Urol. praxi. 2009;10(3):166-167.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Krhut J. Mikční dysfunkce u pacientů s roztroušenou sklerózou. In: Krhut J, et al. Neurourologie. Praha: Galén, 2005: 77-83.
    2. Simon HU, Malhotra B. The pharmacokinetic profile of fesoterodine: similarities and differences to tolterodine. Weiss Med Wkly. 2009; 139(9-10): 146-151. Go to original source...
    3. Chapple CR, Van Kerrebroeck PE, Junemann, et al. Comparison of fesoterodine and tolterodine in patiens with overactive bladder. BJU Int. 2008; 102(9): 1128-1132. Go to original source... Go to PubMed...
    4. Khullar V, Rovner ES, Dmochowski R, et al. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008; 71(5): 839-843. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.